GoldCoin Health Foods Schedules Board Meeting on May 25, 2026 to Approve Q4 Audited Financial Results
GoldCoin Health Foods Limited has intimated BSE Limited of a Board of Directors meeting scheduled for May 25, 2026, pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015. The primary agenda is to consider and approve the audited financial results for the fourth quarter and period ended March 31, 2026. The notice was dated May 18, 2026, and issued by Managing Director Devang P Shah from the company's Ahmedabad registered office.

*this image is generated using AI for illustrative purposes only.
GoldCoin Health Foods Limited has notified BSE Limited of an upcoming Board of Directors meeting, scheduled in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 18, 2026, was issued from the company's registered office in Ahmedabad and signed by Managing Director Devang P Shah.
Board Meeting Details
The following table outlines the key details of the scheduled board meeting:
| Parameter: | Details |
|---|---|
| Meeting Date: | Monday, May 25, 2026 |
| Regulatory Reference: | Regulation 29, SEBI (LODR) Regulations, 2015 |
| Exchange Notified: | BSE Limited |
| Exchange Code: | 538542 |
| Intimation Date: | May 18, 2026 |
| Signatory: | Devang P Shah, Managing Director (DIN: 00633868) |
Agenda for the Meeting
The Board of Directors will convene to deliberate on the following items:
- Audited financial results of the company for the fourth quarter and period ended March 31, 2026
- Any other business with the consent of the Chair
About the Company
GoldCoin Health Foods Limited is incorporated under CIN L15419GJ1989PLC012041, with its registered office located at A-16, 1st Floor, Vardan Tower, Pragatinagar, Naranpura, Ahmedabad – 380 013. The company is listed on BSE Limited and is subject to SEBI's listing obligations and disclosure requirements.
How have GoldCoin Health Foods Limited's revenue and profitability trends evolved over the past few quarters, and what growth trajectory might the Q4 FY2026 audited results reveal?
Given the competitive health foods sector in India, what strategic expansions or new product launches might GoldCoin Health Foods announce alongside or following its Q4 results?
How might GoldCoin Health Foods' financial performance compare to broader industry peers in the listed health foods and FMCG segment on BSE for the same period?


























